article thumbnail

Biobanks VS Biorepositories: The Difference

Cloudbyz

The short answer is that all Biobanks are Biorepositories, but not all Biorepositories are Biobanks. Realistically speaking, the terms “Biobank” and “Biorepository” are used pretty interchangeably. The differences we can point out when someone asks: What is the difference between Biobanks and Biorepositories?

article thumbnail

Manchester to get £60m development to enhance lab space

Drug Discovery World

Three floors of Greenheys will consist of the future HQ for UK Biobank, whose laboratory space will include the latest-generation robotic freezer capable of storing and retrieving up to 20 million biological samples four times faster than current standards. Willmott Dixon will be the lead contractor for the project.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

AstraZeneca analysed rare variant contribution to human disease

Drug Discovery Today

AstraZeneca scientists, based in Cambridge UK, have analysed over 18,000 phenotypes in combination with whole exome sequencing data from nearly 300,000 UK Biobank research participants.

article thumbnail

LifeArc’s £40m research centres to boost research into rare diseases

Drug Discovery World

The centres will bring together scientists and rare disease clinical specialists from across the UK; encouraging new collaborations across different research disciplines and providing improved access to facilities and training. million centre will create a UK-wide biobank of patient samples and models of disease. The £9.4 ($11.7)

article thumbnail

Drug discovery hotspots: Focus on Qatar

Drug Discovery World

As such, Qatar Biobank has emerged within this modernisation to act as a focal point for the country’s goal in preventive and personalised healthcare. It also fits with the country’s preventative health approach that it established in its 2017-2022 Public Health Strategy 5.

article thumbnail

Why early participant engagement is now a top priority in genetic disease research

pharmaphorum

In 2016, scientists behind a study called the Resilience Project analysed genetic data from 589,000+ people and found 13 adults who carried genetic variants that should have resulted in serious – even deadly – childhood disease, but who were apparently healthy. First, start co-development with participants early on in the process.

article thumbnail

Why genomic healthcare data matters in the development of new therapies 

Drug Discovery World

In April 2022, PacBio expanded a research collaboration with Children’s Mercy Kansas City in an effort to improve scientists’ understanding of the genetic underpinnings of rare diseases. The scientists said the results support the use of WGS as a standard diagnostic tool within routine clinical practice and the study 3. .

Genome 98